Primary Site >> Liver Cancer

Gene >> SIX2

Journal: Eur Rev Med Pharmacol Sci. 2016 May;20(9):1712-9.
Title: MicroRNA-185 inhibits cell proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Six2.
Author: Zhu, S-M|Chen, C-M|Jiang, Z-Y|Yuan, B|Ji, M|Wu, F-H|Jin, J
PMID: 27212161
Journal: Biomed Pharmacother. 2018 Aug;104:204-210.
Title: Six2 is negatively correlated with good prognosis and decreases 5-FU sensitivity via suppressing E-cadherin expression in hepatocellular carcinoma cells.
Author: Li, Jian-Wang|Huang, Chun-Zhen|Li, Jian-Hua|Yuan, Jian-Hua|Chen, Qiong-Hui|Zhang, Wei-Fang|Xu, Zhen-Sheng|Liu, Ying-Ping|Li, Yong|Zhan, Mei-Xiao|Lu, Li-Gong
PMID: 29772441
Journal: FEBS Open Bio. 2018 May 30;8(7):1093-1103.
Title: An integrated analysis of genome-wide DNA methylation and gene expression data in hepatocellular carcinoma.
Author: Sun, Xiang-Jun|Wang, Ming-Chun|Zhang, Feng-Hua|Kong, Xiao
PMID: 29988590